Progressive Multiple Sclerosis
Editat de Alastair Wilkinsen Limba Engleză Paperback – 5 sep 2018
The biological processes underlying disease progression are elucidated as are specific pathophysiological mechanisms. The basic science of axonal degeneration and the clinical understanding of progressive multiple sclerosis are discussed in the context of emerging and future therapies for disease progression as are trials which have been and will be conducted for progressive multiple sclerosis. An overview of biomarkers for the disease is included and existing symptomatic therapies for progressive multiple sclerosis are covered in detail.
Progressive Multiple Sclerosis, Second Edition is ideal for both general neurologists and those with a specialist interest in multiple sclerosis. It will also be of interest to neurologists in training and other medical professionals treating this common disease.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 742.85 lei 39-44 zile | |
Springer International Publishing – 5 sep 2018 | 742.85 lei 39-44 zile | |
SPRINGER LONDON – 20 sep 2014 | 1373.21 lei 6-8 săpt. | |
Hardback (1) | 1143.90 lei 3-5 săpt. | |
Springer International Publishing – 13 dec 2017 | 1143.90 lei 3-5 săpt. |
Preț: 742.85 lei
Preț vechi: 781.96 lei
-5% Nou
Puncte Express: 1114
Preț estimativ în valută:
142.15€ • 149.55$ • 117.100£
142.15€ • 149.55$ • 117.100£
Carte tipărită la comandă
Livrare economică 13-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319881324
ISBN-10: 3319881329
Pagini: 307
Ilustrații: IX, 307 p. 21 illus., 6 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:Softcover reprint of the original 2nd ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3319881329
Pagini: 307
Ilustrații: IX, 307 p. 21 illus., 6 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:Softcover reprint of the original 2nd ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
General introduction.- What is disease progression?- Clinical scales of disease progression and disability.- Primary progressive MS.- Epidemiology of progressive multiple sclerosis.- The neuropathology of progressive multiple sclerosis.- Mechanisms of disease progression.- Axonal injury.- Imaging disease progression.- Biomarkers of disease progression.- Symptomatic treatment for progressive multiple sclerosis.- Trials of licenced RRMS disease modifying therapies in progressive MS.- Trials of novel therapies specifically for progressive MS.- Rehabilitation.- Future therapies for progressive multiple sclerosis.
Recenzii
“This book would be most useful to general neurologists and neurology residents, as they would be most likely to care for patients with progressive multiple sclerosis. The book meets the needs of the intended audience … . This is a useful and needed book that concisely summarizes recent clinical trial data on new treatments for progressive multiple sclerosis. There are not many books that address this and therefore neurologists will find this one a useful addition to their library.” (Rashmi B. Halker Singh, Doody's Book Reviews, March, 2018)
Notă biografică
Dr Alastair Wilkins (BA, MB,BChir, PhD(Cantab)) is Reader in Neurology, University of Bristol, and Consultant Neurologist at Southmead Hospital, Bristol, UK. He researches axonal injury in multiple sclerosis and related disorders.
Textul de pe ultima copertă
This revised, updated second edition draws together the basic science, pathology, epidemiology and treatment possibilities in progressive multiple sclerosis. Each chapter addresses specific aspects of progressive multiple sclerosis providing an extensive review of the current literature and a discussion of the likely mechanisms of tissue injury relevant to the disease. New additions to the second edition include a description of clinical scales used to determine levels of disability; recent trials specifically directed at reducing disease progression; rehabilitation; and an in depth discussion of the similarities and differences between primary and secondary multiple sclerosis.
The biological processes underlying disease progression are elucidated as are specific pathophysiological mechanisms. The basic science of axonal degeneration and the clinical understanding of progressive multiple sclerosis are discussed in the context of emerging and future therapies for disease progression as are trials which have been and will be conducted for progressive multiple sclerosis. An overview of biomarkers for the disease is included and existing symptomatic therapies for progressive multiple sclerosis are covered in detail.
Progressive Multiple Sclerosis, Second Edition is ideal for both general neurologists and those with a specialist interest in multiple sclerosis. It will also be of interest to neurologists in training and other medical professionals treating this common disease.
The biological processes underlying disease progression are elucidated as are specific pathophysiological mechanisms. The basic science of axonal degeneration and the clinical understanding of progressive multiple sclerosis are discussed in the context of emerging and future therapies for disease progression as are trials which have been and will be conducted for progressive multiple sclerosis. An overview of biomarkers for the disease is included and existing symptomatic therapies for progressive multiple sclerosis are covered in detail.
Progressive Multiple Sclerosis, Second Edition is ideal for both general neurologists and those with a specialist interest in multiple sclerosis. It will also be of interest to neurologists in training and other medical professionals treating this common disease.
Caracteristici
Provides an update on current treatment and recent trials concerning progressive multiple sclerosis (MS) Guides physicians who manage patients with progressive MS Reviews current theories concerning pathophysiological mechanisms of progressive MS disease progression Relates basic research to potential therapies in progressive MS